12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Tivic Health Systems (TIVC) saw a 25.9% increase, while Acurx Pharmaceuticals (ACXP) dropped by 28.4%. Other notable gainers include Bullfrog AI Hldgs (BFRG), CytoSorbents (CTSO), Dermata Therapeutics (DRMA), ZyVersa Therapeutics (ZVSA), and Windtree Therapeutics (WINT). On the losing side, alongside ACXP, were Definitive Healthcare (DH), Allakos (ALLK), ASLAN Pharma (ASLN), MyMD Pharmaceuticals (MYMD), and Bluejay Diagnostics (BJDX).
January 17, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bullfrog AI Hldgs stock rose 25.37% to $3.31, with a market cap of $20.1 million.
BFRG's notable pre-market rise may attract investor interest, potentially leading to further short-term gains.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
CytoSorbents stock moved upwards by 22.77% to $1.24, with a market cap of $64.6 million.
The pre-market increase for CTSO suggests a bullish outlook that could continue in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Dermata Therapeutics stock increased by 15.68% to $0.52, with a market value of outstanding shares at $1.8 million.
DRMA's stock price rise could lead to short-term trading interest, though the small market cap suggests potential volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Tivic Health Systems stock rose 25.9% to $1.75, with a market value of outstanding shares at $2.5 million.
The significant pre-market increase in TIVC's stock price suggests positive investor sentiment which could lead to a short-term upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Windtree Therapeutics shares moved upwards by 13.51% to $0.67, with a market value of outstanding shares at $3.4 million.
The pre-market rise in WINT's stock price may indicate a positive short-term outlook, though the small market cap suggests potential for volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
ZyVersa Therapeutics stock increased by 15.53% to $0.8, with a market value of outstanding shares at $1.3 million.
ZVSA's pre-market gain could signal short-term investor interest, but the low market cap may lead to volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Acurx Pharmaceuticals shares decreased by 28.4% to $3.4, with a market cap of $46.8 million.
The substantial pre-market decline in ACXP's stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Allakos stock declined by 10.93% to $1.06, with a market cap of $92.7 million.
The pre-market drop in ALLK's stock price suggests a bearish sentiment that could continue in the short term.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
ASLAN Pharma shares fell 9.83% to $0.53, with a market cap of $8.7 million.
ASLN's stock price decrease could lead to a negative short-term trend, with the small market cap adding to the risk of volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Bluejay Diagnostics stock declined by 8.0% to $0.93, with a market cap of $1.6 million.
BJDX's pre-market stock price drop could indicate a negative short-term trend, with the small market cap suggesting the potential for volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Definitive Healthcare shares decreased by 15.24% to $7.79, with a market value of outstanding shares at $906.1 million.
DH's pre-market decline may reflect negative investor sentiment, potentially leading to a short-term decrease in stock price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
MyMD Pharmaceuticals shares declined by 9.17% to $0.18, with a market cap of $9.3 million.
MYMD's decline in pre-market trading may suggest a bearish short-term outlook, and the low market cap could lead to increased volatility.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 70